锂冲击是一个系统，它结合了超声空化和波治疗。它由低频有效的影响，实现了令人难以置信的结果。通过声空化的局部脂肪组织的压力波，导致脂肪细胞随之减少。的压力，同时也打破了胶原的septae，然后释放到皮肤，使光滑的表面。
读更多
所有在4种植牙技术是为全大写，小写或两者牙齿拱恢复的过程。它解决了问题，谁失去了所有的牙齿，并没有太多的保留牙种植体骨离开病人的嘴恢复。这种治疗需要充分的上部和/或降低修复的假牙或上诉。 读更多
By Ben Hirschler LONDON | Mon Nov 5, 2012 3:43am EST LONDON (Reuters) – International drug companies have offered to cap the total amount the Greek government has to pay for its medicines in a bid to resolve a crisis that is jeopardizing both the supply of drugs to patients and drugmakers’ profits. The proposal was set out by the trade group the European Federation of Pharmaceutical Industries and Associations (Efpia) in a letter to the Greek ministers of health and finance, a copy of which was seen by Reuters. In exchange for a ceiling on outpatient pharmaceutical expenditure of 2.88 billion euros ($3.70 billion) in 2012, Efpia wants the government to commit to pay off all outstanding debts and promise not to allow further arrears to build up.
ZURICH | Mon Nov 5, 2012 1:24am EST ZURICH (Reuters) – Novartis said on Monday its drug Votubia had received approval from the European Commission for treating non-cancerous kidney tumors in patients with a rare genetic disease known as tuberous sclerosis complex (TSC). This marks the first approval of a medical treatment in this patient population in Europe, Novartis said.
